Results from the malaria vaccine trial indicate that GA2 immunization provides significant protection, paving the way for ...

The discovery of the pGlu-CSP epitope opens up new avenues for developing next-generation malaria vaccines and treatments.

NIH researchers discover novel class of antibodies that could lead to next generation of interventions against malaria.

A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new ...

NIH researchers discover novel class of anti-malaria antibodies: Bethesda, Maryland Monday, January 6, 2025, 16:00 Hrs [IST] A novel class of antibodies that binds to a previously ...

NIH Researchers Discover Novel Class of Anti-Malaria Antibodies - New Antibodies Could Lead to Generation of Interventions ...

Novel antibodies have the potential to pave the way for the next generation of malaria interventions. Researchers at the ...

Malaria is a mosquito-borne disease that is caused by Plasmodium parasites. Patients with malaria experience flu-like symptoms and, in severe cases, the disease can progress to neurological ...

Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for malaria.

A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new ...

A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new ...